PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Active, not recruiting	Phase 2	2025-12-11		NCT05340270

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Afﬁliated Hospital of North Sichuan Medical College	16
First People's Hospital of Yulin	10
Fourth Affiliated Hospital of Guangxi Medical University	5
Guangxi Medical University	14
Guigang People's Hospital	4
Hainan People's Hospital	12
LiuZhou People's Hospital	15
Wuzhou Red Cross Hospital	20

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	66